Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hive patients may get more time between shots

NCT ID NCT05916937

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times

Summary

This study looks at whether people with chronic spontaneous urticaria (long-lasting hives) who are doing well on omalizumab shots every 4 weeks can safely stretch the time between shots without losing control of their symptoms. About 40 adults whose hives are well-controlled will take part. If successful, this could mean fewer clinic visits and less medication for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Dermatology, Bispebjerg Hospital

    RECRUITING

    Copenhagen, Copenhagen N, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.